figure 5

[sbellan61]

make figure 5 by showing how trial size impacts the ability of delayed vacc copmarator to limit individual risk spending. show 3 example clusters to allow individual lines to be seen.

write discussion/conclusion

make supp figures:

1. show all clusters, show total risk, avertable, averted
2. show design figure
3. any other figures that might be helpful

supp table that describes each trial design in detail (including post-efficacy rollout)

[sbellan61]

waiting on 10 clus results to finishin running and then will do this for the updated results